Study to Assess the Safety and Efficacy of Enbrel Administered by Sofusa DoseConnect for Rheumatoid Arthritis

NCT04559412 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DEVICE: Sofusa DoseConnect
DRUG: Enbrel

Sponsor

Sorrento Therapeutics, Inc.